These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7932522)

  • 1. Synthesis, resolution, and SAR of (+/-)-2-amino-N-methyl-alpha-(3-methyl-2-thienyl)benzeneethanamine++ + and related analogs as noncompetitive NMDA antagonists with neuroprotective properties.
    Martin LL; Lee GE; Lee TB; Rush DK; Wilmot CA; Paulus E; Elben U; Grome JJ; Porsche-Wiebking E; Rudolphi KA
    J Med Chem; 1994 Sep; 37(19):3008-15. PubMed ID: 7932522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical anticonvulsant and neuroprotective profile of 8319, a non-competitive NMDA antagonist.
    Fielding S; Wilker JC; Chernack J; Ramirez V; Wilmot CA; Martin LL; Payack JF; Cornfeldt ML; Rudolphi KA; Rush DK
    Prog Clin Biol Res; 1990; 361():533-41. PubMed ID: 2290851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist.
    Ferkany JW; Hamilton GS; Patch RJ; Huang Z; Borosky SA; Bednar DL; Jones BE; Zubrowski R; Willetts J; Karbon EW
    J Pharmacol Exp Ther; 1993 Jan; 264(1):256-64. PubMed ID: 8423528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on cerebral protective agents. X. Synthesis and evaluation of anticonvulsant activities for novel 4,5,6,7-tetrahydrothieno[3,3-c]pyridines and related compounds.
    Ohkubo M; Kuno A; Katsuta K; Ueda Y; Shirakawa K; Nakanishi H; Kinoshita T; Takasugi H
    Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):778-84. PubMed ID: 8681410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on cerebral protective agents. IX. Synthesis of novel 1,2,3,4-tetrahydroisoquinolines as N-methyl-D-aspartate antagonists.
    Ohkubo M; Kuno A; Katsuta K; Ueda Y; Shirakawa K; Nakanishi H; Nakanishi I; Kinoshita T; Takasugi H
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):95-102. PubMed ID: 8582046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebroside-A provides potent neuroprotection after cerebral ischaemia through reducing glutamate release and Ca²⁺ influx of NMDA receptors.
    Li L; Yang R; Sun K; Bai Y; Zhang Z; Zhou L; Qi Z; Qi J; Chen L
    Int J Neuropsychopharmacol; 2012 May; 15(4):497-507. PubMed ID: 21557879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted?
    Buchan AM
    Cerebrovasc Brain Metab Rev; 1990; 2(1):1-26. PubMed ID: 2144995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships in a series of 2(1H)-quinolones bearing different acidic function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties.
    Desos P; Lepagnol JM; Morain P; Lestage P; Cordi AA
    J Med Chem; 1996 Jan; 39(1):197-206. PubMed ID: 8568808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of indole-2-carboxylate derivatives as antagonists of N-methyl-D-aspartate receptor activity at the associated glycine recognition site.
    Hood WF; Gray NM; Dappen MS; Watson GB; Compton RP; Cordi AA; Lanthorn TH; Monahan JB
    J Pharmacol Exp Ther; 1992 Aug; 262(2):654-60. PubMed ID: 1386886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia.
    Gotti B; Duverger D; Bertin J; Carter C; Dupont R; Frost J; Gaudilliere B; MacKenzie ET; Rousseau J; Scatton B
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1211-21. PubMed ID: 2849668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
    Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
    J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
    Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of phenytoin with noncompetitive N-methyl-D-aspartate antagonists in a model of focal brain ischemia in rat.
    Boxer PA; Cordon JJ; Mann ME; Rodolosi LC; Vartanian MG; Rock DM; Taylor CP; Marcoux FW
    Stroke; 1990 Nov; 21(11 Suppl):III47-51. PubMed ID: 2237985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. -(S)-Alpha-phenyl-2-pyridine-ethanamine Dihydrochloride-, a low affinity uncompetitive N-methyl-D-aspartic acid antagonist, is effective in rodent models of global and focal ischemia.
    Cregan EF; Peeling J; Corbett D; Buchan AM; Saunders J; Auer RN; Gao M; Mccarthy DJ; Eisman MS; Campbell TM; Murray RJ; Stagnitto ML; Palmer GC
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1412-24. PubMed ID: 9400017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
    Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective interaction effects of NMDA and AMPA receptor antagonists in an in vitro model of cerebral ischemia.
    Arias RL; Tasse JR; Bowlby MR
    Brain Res; 1999 Jan; 816(2):299-308. PubMed ID: 9878799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excitatory amino acid binding sites in the rat hippocampus after transient forebrain ischemia.
    Onodera H; Araki T; Kogure K
    J Cereb Blood Flow Metab; 1989 Oct; 9(5):623-8. PubMed ID: 2550493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
    Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM
    Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of action.
    Ornstein PL; Schoepp DD; Arnold MB; Leander JD; Lodge D; Paschal JW; Elzey T
    J Med Chem; 1991 Jan; 34(1):90-7. PubMed ID: 1825117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do N-methyl-D-aspartate antagonists have disproportionately greater effects on brain swelling than on ischemic damage in focal cerebral infarction?
    Park CK; McCulloch J; Jung DS; Kang JK; Choi CR
    Acta Neurochir Suppl (Wien); 1994; 60():279-81. PubMed ID: 7976566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.